Existing and emerging inhibitors of CSF1R may prevent neurodegeneration in models of Alzheimer’s disease [12] and traumatic brain injury [13, 14], which supports further research into the therapeutic potential of CSF1R antagonism in select neurologic conditions. Here, CSF1R is linked to Alzheimer disease.